Voltage-activated calcium channels: Targets of antiepileptic drug therapy?

Alessandro Stefani, Francesca Spadoni, Giorgio Bernardi

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Voltage-gated calcium currents play important roles in controlling neuronal excitability. They also contribute to the epileptogenic discharge, including seizure maintenance and propagation. In the past decade, selective calcium channel blockers have been synthesized, aiding in the analysis of calcium channel subtypes by patch-clamp recordings. It is still a matter of debate whether any of the currently available antiepileptic drugs (AEDs) inhibit these conductances as part of their mechanism of action. We tested oxcarbazepine, lamotrigine, and felbamate and found that they consistently inhibited voltage-activated calcium currents in cortical and striatal neurons at clinically relevant concentrations. Low micro-molar concentrations of GP 47779 (the active metabolite of oxcarbazepine) and lamotrigine reduced calcium conductances involved in the regulation of transmitter release. In contrast, felbamate blocked nifedipine-sensitive conductances at concentrations significantly lower than those required to modify N-methyl-D- aspartate (NMDA) responses or sodium currents. Aside from contributing to AED efficacy, this mechanism of action may have profound implications for preventing fast-developing cellular damage related to ischemic and traumatic brain injuries. Moreover; the effects of AEDs on voltage-gated calcium signals may lead to new therapeutic strategies for the treatment of neurodegenerative disorders.

Original languageEnglish
Pages (from-to)959-965
Number of pages7
JournalEpilepsia
Volume38
Issue number9
DOIs
Publication statusPublished - Sep 1997

Fingerprint

felbamate
Calcium Channels
Anticonvulsants
Calcium
Drug Therapy
10,11-dihydro-10-hydroxycarbamazepine
Corpus Striatum
Calcium Channel Blockers
N-Methylaspartate
Nifedipine
Neurodegenerative Diseases
Seizures
Sodium
Maintenance
Neurons
Therapeutics
lamotrigine
oxcarbazepine

Keywords

  • Antiepileptic drugs
  • Calcium conductances
  • Neuronal hyperexcitability
  • Neuroprotective agents
  • Patch-clamp

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Voltage-activated calcium channels : Targets of antiepileptic drug therapy? / Stefani, Alessandro; Spadoni, Francesca; Bernardi, Giorgio.

In: Epilepsia, Vol. 38, No. 9, 09.1997, p. 959-965.

Research output: Contribution to journalArticle

Stefani, Alessandro ; Spadoni, Francesca ; Bernardi, Giorgio. / Voltage-activated calcium channels : Targets of antiepileptic drug therapy?. In: Epilepsia. 1997 ; Vol. 38, No. 9. pp. 959-965.
@article{f32394c586234708ac6e89c06c26153d,
title = "Voltage-activated calcium channels: Targets of antiepileptic drug therapy?",
abstract = "Voltage-gated calcium currents play important roles in controlling neuronal excitability. They also contribute to the epileptogenic discharge, including seizure maintenance and propagation. In the past decade, selective calcium channel blockers have been synthesized, aiding in the analysis of calcium channel subtypes by patch-clamp recordings. It is still a matter of debate whether any of the currently available antiepileptic drugs (AEDs) inhibit these conductances as part of their mechanism of action. We tested oxcarbazepine, lamotrigine, and felbamate and found that they consistently inhibited voltage-activated calcium currents in cortical and striatal neurons at clinically relevant concentrations. Low micro-molar concentrations of GP 47779 (the active metabolite of oxcarbazepine) and lamotrigine reduced calcium conductances involved in the regulation of transmitter release. In contrast, felbamate blocked nifedipine-sensitive conductances at concentrations significantly lower than those required to modify N-methyl-D- aspartate (NMDA) responses or sodium currents. Aside from contributing to AED efficacy, this mechanism of action may have profound implications for preventing fast-developing cellular damage related to ischemic and traumatic brain injuries. Moreover; the effects of AEDs on voltage-gated calcium signals may lead to new therapeutic strategies for the treatment of neurodegenerative disorders.",
keywords = "Antiepileptic drugs, Calcium conductances, Neuronal hyperexcitability, Neuroprotective agents, Patch-clamp",
author = "Alessandro Stefani and Francesca Spadoni and Giorgio Bernardi",
year = "1997",
month = "9",
doi = "10.1111/j.1528-1157.1997.tb01477.x",
language = "English",
volume = "38",
pages = "959--965",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "9",

}

TY - JOUR

T1 - Voltage-activated calcium channels

T2 - Targets of antiepileptic drug therapy?

AU - Stefani, Alessandro

AU - Spadoni, Francesca

AU - Bernardi, Giorgio

PY - 1997/9

Y1 - 1997/9

N2 - Voltage-gated calcium currents play important roles in controlling neuronal excitability. They also contribute to the epileptogenic discharge, including seizure maintenance and propagation. In the past decade, selective calcium channel blockers have been synthesized, aiding in the analysis of calcium channel subtypes by patch-clamp recordings. It is still a matter of debate whether any of the currently available antiepileptic drugs (AEDs) inhibit these conductances as part of their mechanism of action. We tested oxcarbazepine, lamotrigine, and felbamate and found that they consistently inhibited voltage-activated calcium currents in cortical and striatal neurons at clinically relevant concentrations. Low micro-molar concentrations of GP 47779 (the active metabolite of oxcarbazepine) and lamotrigine reduced calcium conductances involved in the regulation of transmitter release. In contrast, felbamate blocked nifedipine-sensitive conductances at concentrations significantly lower than those required to modify N-methyl-D- aspartate (NMDA) responses or sodium currents. Aside from contributing to AED efficacy, this mechanism of action may have profound implications for preventing fast-developing cellular damage related to ischemic and traumatic brain injuries. Moreover; the effects of AEDs on voltage-gated calcium signals may lead to new therapeutic strategies for the treatment of neurodegenerative disorders.

AB - Voltage-gated calcium currents play important roles in controlling neuronal excitability. They also contribute to the epileptogenic discharge, including seizure maintenance and propagation. In the past decade, selective calcium channel blockers have been synthesized, aiding in the analysis of calcium channel subtypes by patch-clamp recordings. It is still a matter of debate whether any of the currently available antiepileptic drugs (AEDs) inhibit these conductances as part of their mechanism of action. We tested oxcarbazepine, lamotrigine, and felbamate and found that they consistently inhibited voltage-activated calcium currents in cortical and striatal neurons at clinically relevant concentrations. Low micro-molar concentrations of GP 47779 (the active metabolite of oxcarbazepine) and lamotrigine reduced calcium conductances involved in the regulation of transmitter release. In contrast, felbamate blocked nifedipine-sensitive conductances at concentrations significantly lower than those required to modify N-methyl-D- aspartate (NMDA) responses or sodium currents. Aside from contributing to AED efficacy, this mechanism of action may have profound implications for preventing fast-developing cellular damage related to ischemic and traumatic brain injuries. Moreover; the effects of AEDs on voltage-gated calcium signals may lead to new therapeutic strategies for the treatment of neurodegenerative disorders.

KW - Antiepileptic drugs

KW - Calcium conductances

KW - Neuronal hyperexcitability

KW - Neuroprotective agents

KW - Patch-clamp

UR - http://www.scopus.com/inward/record.url?scp=0030848858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030848858&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1157.1997.tb01477.x

DO - 10.1111/j.1528-1157.1997.tb01477.x

M3 - Article

C2 - 9579933

AN - SCOPUS:0030848858

VL - 38

SP - 959

EP - 965

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 9

ER -